Wed.Jun 04, 2025

article thumbnail

NICE recommends Sogroya for growth hormone deficiency in children

Pharma Times

Treatment provides option for children with growth failure

115
115
article thumbnail

What is Digital Communication: Comprehensive Explanation with Examples

Viseven

Have you ever stopped to wonder how your communication methods are shaping patient loyalty? It’s easy to assume patients will stay if the care is good — but is that enough in today’s digital world? A 2024 survey from Bandwidth revealed that nearly half of patients would consider switching healthcare providers if their communication needs weren’t met.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

Collaborations result in antibiotic resistance breakthrough

World Pharma News

University of Otago - Ōtākou Whakaihu Waka researchers have been part of two groundbreaking studies in the battle against drug resistant strains of Mycobacterium tuberculosis, the cause of tuberculosis. Co-author on both studies, Dr Matthew McNeil, of the Department of Microbiology and Immunology, describes tuberculosis as a "massive public health problem" that is challenging to solve.

52
article thumbnail

FDA to use new review tool on Sarepta’s gene therapy work

BioPharma Dive

The company is one of the first to receive a “platform technology designation,” which could speed the review of certain gene therapy applications it later brings to the regulator.

78
article thumbnail

Navigating Payroll Compliance: Future-Proofing Payroll in an Evolving Regulatory Landscape

Speaker: Jennifer Hill

Payroll compliance is a cornerstone of business success, yet for small and midsize businesses, it’s becoming increasingly challenging to navigate the ever-evolving landscape of federal, state, and local regulations. Mistakes can lead to costly penalties and operational disruptions, making it essential to adopt advanced solutions that ensure accuracy and efficiency.

article thumbnail

Redwire gains Aspera contract for space-based cancer research

Pharmaceutical Technology

Redwire Corporation has secured a contract from Aspera Biomedicines to carry out space-based research on a cancer treatment.

75

More Trending

article thumbnail

USP Opens Advanced Technology Lab in Maryland

PharmaTech

The new lab will be used to develop and scale innovations for the production of medicines and to help secure the supply chain.

89
article thumbnail

Bispecific cancer drugs, data caveats and funding alarms: 3 takeaways from ASCO

BioPharma Dive

Breast cancer study results impressed at this year’s meeting, but raised new questions. Doctors also wrestled with how best to use new bispecific antibodies, and expressed concern about looming cuts to science funding.

71
article thumbnail

ASCO 25: J&J combo pill may see wider use in prostate cancer

pharmaphorum

AMPLITUDE study of J&J's Akeega could extend the use of PARP inhibitors to hormone-responsive prostate cancer

66
article thumbnail

European Council announces progress on pharmaceutical package adoption

European Pharmaceutical Review

The European Council is set to begin negotiations with the European Parliament about the pharma package, having agreed its position on the new rules. The proposals comprise of a regulation and directive. Once in place, the package will represent the biggest pharmaceutical reform in over twenty years. Two of its main aims is improving competitiveness of the EU pharmaceutical industry and reducing administrative burden.

article thumbnail

From Diagnosis to Delivery: How AI is Revolutionizing the Patient Experience

Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.

The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven

article thumbnail

Hims & Hers buys Zava to form European beachhead

pharmaphorum

US telehealth company Hims & Hers has reached a deal to buy its UK counterpart Zava as part of a broader push into Europe

64
article thumbnail

Will AI Replace Pharma Jobs? What Experts Predict

Pharma Marketing Network

Artificial intelligence is no longer a futuristic conceptit’s here and evolving fast. From automating clinical trials to generating marketing insights, AI in pharma jobs is transforming the healthcare industry. But with automation accelerating, a pressing question emerges: will AI replace pharma jobs or enhance them? Table of Contents The Rise of AI in Pharma Roles Most at Risk (and Why) Emerging Opportunities Through AI Strategic Adaptation for the Pharma Workforce Conclusion FAQs The Ris

article thumbnail

ASCO 25: Sanofi hopes on-body delivery will boost Sarclisa

pharmaphorum

Can a new on-body injector version of Sanofi's Sarclisa help it claim market share from J&J's rival top-selling Darzalex in multiple myeloma

66
article thumbnail

Ascletis’s daily acne tablet set for China review after Phase III win

Pharmaceutical Technology

The Phase III trial, conducted by Chinese license partner Ascletis, produced strong results for denifanstat compared to potential rivals.

52
article thumbnail

Why Every Small Business Needs an HCM Solution: A Comprehensive Guide

Managing HR tasks like payroll, compliance, and employee data can overwhelm small businesses. That’s where a Human Capital Management (HCM) solution comes in. Our eBook, Why Every Small Business Needs an HCM Solution: A Comprehensive Guide , shows how an HCM system automates tedious processes, ensuring your business stays compliant and efficient. You’ll learn how to simplify payroll, eliminate costly errors, and empower your employees with self-service tools.

article thumbnail

MSD rumoured to be eyeing $3bn+ MoonLake takeover

pharmaphorum

Faced with the looming loss of patent protection for Keytruda, MSD is reported to be interested in buying Swiss immunology player MoonLake

59
article thumbnail

Roche extends SMA market lead with Evrysdi tablet approval in Europe

Pharmaceutical Technology

Already offering the only non-invasive treatment for SMA in liquid form, Roches Evrysdi now comes as a tablet.

52
article thumbnail

Ascletis says oral acne drug shows "exceptional efficacy"

pharmaphorum

Phase 3 results for Ascletis' novel acne candidate have set up filings in China and bode well for a similar drug being developed by Sagimet in the US

59
article thumbnail

Magazine: Are regulators keeping pace with AI adoption in clinical trials?

Pharmaceutical Technology

In this issue: assessing the regulators' role as AI in clinical trials evolves, the potential for a newborn screening refresh in the US, ATS 2025 commentary, and more

52
article thumbnail

Best Practices to Streamline Compensation Management: A Foundation for Growth

Speaker: Joe Sharpe and James Carlson

Payroll optimization can be one of the most time-consuming and complex factors of small business management. Yet, organizations that crack the code on streamlining employee compensation often discover innovative avenues for growth. With the right strategies in place, outsourcing and streamlining payroll processes can result in substantial time and resource savings.

article thumbnail

The Tariff Effect: Greater Supply Chain Prepares for Repercussions

Pharmaceutical Commerce

Potential import taxes on pharma goods entering the United States continue to have effects on the industry in more ways than one.

59
article thumbnail

Study: LYR-210 Shows Promise in Chronic Rhinosinusitis with Nasal Polyps

Pharmacy Times

New findings show LYR-210's potential to significantly alleviate chronic rhinosinusitis symptoms, offering hope for patients with nasal inflammation and polyps.

44
article thumbnail

Pharma Pulse 6/4/25: Five Critical Challenges in Investigator Site Selection and How Clinical Data Science Can Solve Them; Wegovy Use Up 50% Among US Teens

Pharmaceutical Commerce

Pharmaceutical Commerce connects biopharma executives to insights on business processes, technologies, and strategies for taking approved drugs to market.

52
article thumbnail

Agenus and Zydus sign agreements for botensilimab and balstilimab

Pharmaceutical Technology

Agenus has signed $141m partnership agreements with Zydus Lifesciences, expanding patient access to BOT/BAL.

52
article thumbnail

Enhance Healthcare Efficiency With Top Payroll & HCM Services

Running a healthcare facility requires precision and care, not just for patients but also for your staff. Our guide, "A Buyer’s Guide to Payroll & HCM Services," helps healthcare providers choose the best provider. Efficient payroll management ensures timely, accurate payments, critical for maintaining staff morale and trust. Compliance support helps navigate complex healthcare regulations and avoid costly fines.

article thumbnail

Driving Supply Chain Resilience

Pharmaceutical Commerce

In the final part of his Pharma Commerce video interview, Scott Tillman, Logilitys senior vice president of innovation, discusses how uncertainty can help reshape the way organizations prioritize supply chain investments.

52
article thumbnail

EC approves Takeda ADC plus chemo for stage IIb Hodgkin’s lymphoma

Pharmaceutical Technology

The European Commission (EC) has granted approval for Takeda's antibody-drug conjugate (ADC) Adcetris (brentuximab vedotin).

52
article thumbnail

ASCO 2025: Fixed-Duration Treatment Emerges as Future of Multiple Myeloma Management

Pharmacy Times

Saad Usmani, MD, MBA, FACP, FASCO, explores treatment duration, patient characteristics, and toxicity profiles in transplant-ineligible patients with newly diagnosed multiple myeloma.

29
article thumbnail

The MAHA Assessment’s Implications: Drugs (Part One)

FDA Law Blog: Biosimilars

By Mark A. Tobolowsky & Ricardo Carvajal Among other things, EO 14212 established the Make America Healthy Again (MAHA) Commission (with HHS Secretary Kennedy as its Chair) and tasked it with a tall order: submission to the President of an Assessment that tackled 10(!) complex public health issues within 100(!) days. Perhaps it was inevitable that the Commission would turn to AI for help, as seems to have been the case in light of media reports that the Assessment as originally published in

article thumbnail

Position Your Pharmacy for Expansion

Speaker: Chris Antypas and Josh Halladay

Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.

article thumbnail

Neoadjuvant Osimertinib With or Without Chemotherapy Improves Response in Resectable EGFRm NSCLC

Pharmacy Times

Results from the NeoADAURA trial demonstrate the sustained efficacy of osimertinib in patients with epidermal growth factor receptor-mutated (EGFRm) non-small-cell lung cancer (NSCLC).

article thumbnail

Dismantling CDC’s chronic disease center ‘looks pretty devastating’ to public health experts

STAT

Chronic disease isn’t going away, but a national center devoted to its prevention may be, a prospect that is alarming agency insiders and public health officials across the country. The Department of Health and Human Services’ budget for 2026 , released Friday, proposed $14 billion in discretionary funding for programs that aim to reverse the chronic disease epidemic , but it would also abolish the CDC’s National Center for Chronic Disease Prevention and Health Promotion.

363
363
article thumbnail

Fixed-Duration Ibrutinib Plus Venetoclax Shows Long-Term Efficacy in First-Line CLL/SLL Treatment

Pharmacy Times

Ibrutinib plus venetoclax shows promising long-term survival rates, including those who are considered high risk.

26